Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy [NA]
This update notes that a clinical trial is recruiting to test whether high-intensity interval training improves cognitive function in breast…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast Cancer [NA]
This clinical trial update covers a study evaluating a radiation therapy boost given before surgery for non-metastatic breast cancer. The tr…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: CDK4/6 Inhibitors Combined With Standard Adjuvant Endocrine Therapy in High-Risk, HR+/HER2+ Early Breast Cancer Patients(CHESS) [Phase 3]
Phase 3 CHESS trial evaluating CDK4/6 inhibitors added to standard adjuvant endocrine therapy for high-risk HR+/HER2+ early breast cancer; c…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast Cancer [Phase 2]
A Phase 2 trial is evaluating ctDNA-guided de-escalation of adjuvant chemotherapy using dalpiciclib in HR-positive, HER2-negative breast can…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Negative Breast Cancer and Other Solid Tumors [Phase 1]
A Phase 1 trial evaluating BL-M17D1 in locally advanced or metastatic breast cancer (HER2 positive and negative) and other solid tumors is c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients [NA]
This clinical trial update describes a self-monitoring platform to track medication safety concerns in cancer patients, sponsored by the Uni…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Adjuvant Regional Nodal Radiation Therapy for One Week in Breast Cancer [NA]
A clinical trial evaluating a one-week adjuvant regional nodal radiation therapy for breast cancer. The study is currently ACTIVE_NOT_RECRUI…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer [NA]
Rutgers is recruiting for a clinical study to investigate metabolic pathways in hormone receptor-positive/HER2-negative breast cancer.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Study of GNC-077 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors [Phase 1]
A Phase 1 clinical trial evaluating GNC-077 in locally advanced or metastatic breast cancer and other solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03) [Phase 3]
Phase 3 clinical trial evaluating antivascular therapy in combination with chemotherapy versus chemotherapy alone as adjuvant treatment for …
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Breast Cancer Education to Prisoner Women [NA]
A completed clinical trial evaluating breast cancer education for women prisoners, sponsored by Hitit University.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: EXoPERT EMERALD Clinical Study
Clinical trial update indicates the EXoPERT EMERALD study is currently recruiting across multiple cancer indications, including breast, colo…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Neoadjuvant Trastuzumab-rezetecan Plus Pertuzumab or Nab-Paclitaxel, Carboplatin, Trastuzumab, and Pyrotinib After Suboptimal Response to Neoadjuvant Dual HER2-Targeted Therapy Combined With Chemotherapy in HER2-Positive Early Breast Cancer [Phase 2]
Phase 2 neoadjuvant trial evaluating trastuzumab-rezetecan with either pertuzumab or a nab-paclitaxel/carboplatin/trastuzumab/pyrotinib regi…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Radiofrequency and Exercise-based Rehabilitation on Symptoms Associated With Pelvic Floor Dysfunctions in Breast Cancer [NA]
A clinical trial evaluating radiofrequency and exercise-based rehabilitation to address pelvic floor dysfunction symptoms in breast cancer p…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Huaier Granule and Proteinuria [Phase 2]
Phase 2 clinical trial update for Huaier Granule in proteinuria and breast cancer patients, with recruitment not yet started.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Accuracy of Sono-mammographic Features in Molecular Classification of Breast Cancer
A clinical trial evaluating whether sonomammographic features can accurately classify breast cancer at the molecular level. The study is cur…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Testing Home-based Exercise Strategies in Underserved Minority Cancer Patients Undergoing Chemotherapy: the THRIVE Study [NA]
This clinical trial update describes the THRIVE study, which investigates home-based exercise strategies for underserved minority cancer pat…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Axelopran in Advanced Cancers [Phase 2]
Axelopran is being studied in a Phase 2 trial across several advanced cancers, but the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Study of BL-M07D1 Versus Investigator's Choice of Chemotherapy in Patients With HER2-low Recurrent/Metastatic Breast Cancer [Phase 3]
A Phase 3 trial comparing BL-M07D1 to investigator's choice chemotherapy in HER2-low recurrent/metastatic breast cancer is currently recruit…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers [Phase 2]
Phase 2 clinical trial evaluating standard-of-care chemotherapy with or without tocilizumab for metastatic breast cancer, including triple-n…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: The Association Between Age-related Peripheral Blood Components and Treatment Efficacy in Breast Cancer
This clinical trial examines whether age-related peripheral blood components affect treatment efficacy in breast cancer and is currently rec…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer [Phase 2]
A Phase 2 clinical trial is investigating tirzepatide for weight loss as an intervention in early-stage hormone receptor-positive, HER2-nega…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Financial Toxicity in Patients With Early-stage Breast Cancer
A National Cancer Institute-sponsored clinical trial in Naples is investigating financial toxicity in patients with early-stage breast cance…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort [Phase 2]
Phase 2 clinical trial update evaluating gene signatures to guide therapy for HR-positive metastatic breast cancer in a diverse cohort; the …
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study [NA]
Clinical trial update about a culturally based brief expressive writing intervention to improve health in Chinese immigrant breast cancer su…